International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspective. | Ecancermedicalscience;7: 321, 2013. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspective.

Shash, Emad; Negrouk, Anastassia; Marreaud, Sandrine; Golfinopoulos, Vassilis; Lacombe, Denis; Meunier, Francoise.

Affiliation

Shash E; EORTC, Avenue E. Mounier 83, B-1200 Brussels, Belgium.

Ecancermedicalscience ; 7: 321, 2013.

Article in En | MEDLINE | ID: mdl-23717342

Key words

clinical trials; international collaboration; rare cancer

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Language: En Journal: Ecancermedicalscience Year: 2013 Document type: Article Affiliation country: Belgium Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Language: En Journal: Ecancermedicalscience Year: 2013 Document type: Article Affiliation country: Belgium Country of publication: United kingdom